Bionano Genomics, Inc. financial data

Symbol
BNGO on Nasdaq
Location
9540 Towne Centre Drive, Suite 100, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
BioNanomatrix Inc (to 3/24/2011)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 140 % -41.7%
Quick Ratio 46.1 % -22.9%
Debt-to-equity 82.5 % +82.8%
Return On Equity -181 % -28.8%
Return On Assets -99.3 % -2.46%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.01M shares -94.5%
Common Stock, Shares, Outstanding 1.87M shares +145%
Entity Public Float 41.6M USD -79.3%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 1.27M shares +123%
Weighted Average Number of Shares Outstanding, Diluted 1.27M shares +123%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 30.8M USD -14.8%
Research and Development Expense 24.8M USD -54.1%
Costs and Expenses 104M USD -53.6%
Operating Income (Loss) -104M USD +51.7%
Nonoperating Income (Expense) -8M USD +53.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -112M USD +51.8%
Income Tax Expense (Benefit) 33K USD -46.8%
Net Income (Loss) Attributable to Parent -112M USD +51.8%
Earnings Per Share, Basic -88.1 USD/shares
Earnings Per Share, Diluted -88.1 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.17M USD -48.9%
Accounts Receivable, after Allowance for Credit Loss, Current 4.75M USD -49%
Inventory, Net 13.3M USD -51.9%
Other Assets, Current 1.32M USD +35%
Assets, Current 39.5M USD -71.8%
Property, Plant and Equipment, Net 19.2M USD -17.7%
Operating Lease, Right-of-Use Asset 1.8M USD -68%
Intangible Assets, Net (Excluding Goodwill) 9.71M USD -71.4%
Goodwill 0 USD -100%
Other Assets, Noncurrent 2.75M USD -62.9%
Assets 76.7M USD -64.2%
Accounts Payable, Current 6.96M USD -33%
Employee-related Liabilities, Current 1.98M USD -60.6%
Accrued Liabilities, Current 5.64M USD -30.3%
Contract with Customer, Liability, Current 1.13M USD +44.1%
Liabilities, Current 37.3M USD -62.7%
Contract with Customer, Liability, Noncurrent 267K USD +73.4%
Operating Lease, Liability, Noncurrent 145K USD -96%
Liabilities 41.3M USD -65.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 27K USD +17.4%
Retained Earnings (Accumulated Deficit) -693M USD -19.3%
Stockholders' Equity Attributable to Parent 35.4M USD -63.2%
Liabilities and Equity 76.7M USD -64.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.1M USD +13.2%
Net Cash Provided by (Used in) Financing Activities -21.6M USD -245%
Net Cash Provided by (Used in) Investing Activities 47.6M USD +188%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 1.87M shares +145%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.19M USD -122%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.57M USD -47.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.62M USD +7295%
Deferred Tax Assets, Valuation Allowance 140M USD +26.9%
Deferred Tax Assets, Gross 144M USD +19.7%
Operating Lease, Liability 3.14M USD -45.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -112M USD +51.6%
Lessee, Operating Lease, Liability, to be Paid 3.41M USD -47.2%
Property, Plant and Equipment, Gross 46.1M USD +8.63%
Operating Lease, Liability, Current 2.99M USD +38.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 544K USD -80.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.61M USD -2.83%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +12%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 270K USD -61.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 254K USD -65.2%
Deferred Tax Assets, Operating Loss Carryforwards 114M USD +23.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 6.94M USD +39.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD -100%
Operating Lease, Payments 669K USD +3.88%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 3.01M USD -5.74%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 9.74M USD -35.9%
Interest Expense 5.17M USD +1639%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%